Human Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
- Adult women (age between 18 and 40) who stored the ovary before cancer therapy.
- Adult women who completed cancer therapy and are in remission.
- Adult women who desire to conceive and are ready to have a baby.
- Age under 18 or over 40 years old
- Women with a disease at high risk for ovarian metastasis (such as leukemia)
- Women with contraindication for surgery
- Women with contraindication for pregnancy
- Psychological instability to sustain pregnancy (diagnosed by a psychiatrist)
- Women who are HIV Positive
Type of Study:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Comparision of orthotopic and heterotopic autotransplantation
The main purpose of this study is to investigate restoration of ovarian function and fertility by autotransplantation of human ovarian tissue using heterotopic and orthotopic techniques
Sam Kim, MD
The University of Kansas Medical Center
United States: Institutional Review Board
- Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
- women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
- who are in remission (no recurrence of disease for 5 years),
- who are in normal organ function and have no contraindication for surgery or pregnancy, and
- who wish to restore ovarian function using stored ovarian tissue.
|The University of Kansas Medical Center
||Kansas City, Kansas 66160